Product Categories
| Country: | China |
|---|---|
| Tel: | 0551-055168665055 |
| Mobile: | +8618616906106 |
| E-mail: | sales@trywchem.com |
| QQ: | 498380429 |
| Skype: | Chat Now! |
| Address: | No.23,lntersection of Fenglehe Avenue and eivang Road, Huagang Town,Feixi County, Heifei, Anhui, China. |
|
Hefei Tianrui Pharmaceutical Chemical Co., Ltd. is located in the Industrial Park of Huagang Town, Feixi County, Hefei City. With excellent R&D capabilities, a complete set of complementary industrialization support, and an international CGMP quality management system, Tianrui is committed to providing professional technical services and commercialization of small molecule specialty APIs, CGMP standard intermediates, functional pharmaceutical excipients, and MRNA vaccine vectors for domestic and overseas well-known pharmaceutical enterprises.
The company has independently developed and commercialized a range of new drug products, including Roflumilast, Rivaroxaban, Ezetimibe, Dasatinib, Repaglinide, Prucalopride Succinate, Salcaprozate sodium (8-(2-hydroxybenzamido)octanoate), Vandetanib, Garenoxacin, Ropinirole hydrochloride, Conivaptan hydrochloride, Crizotinib, Olaparib, Macitentan, Difamilast, Tepotinib, Tanimilast, Foscarbidopa, etc. Among them, Salcaprozate sodium (8-(2-hydroxybenzamido)octanoate) has successfully obtained registration numbers from both the Chinese CDE and the US FDA (CDE registration number: F20220000072; USDMF number: 037135).
Meanwhile, we also have strength of long chain intermediates such as 8-Bromooctanoic Acid, 8-Aminooctanoic Acid, Methyl 8-bromooctanoate, Ethyl 8-bromooctanoate, 6-Bromohexanoic Acid, Ethyl 7-bromooctanoate, Diphenyl Phosphate, Tetrabenzyl pyrophosphate, 4-(Boc-Amino)cyclohexanone, etc.
The products are mainly exported to Europe, North America, India, Japan, Korea and other countries, and we can provide the documentation support and audit requirements of the said corresponding regulatory markets.
Tianrui Pharmaceutical is dedicated to the lifelong mission of striving for human health, continuously updating excellent products and services, and making contributions to breaking through the global barriers in the pharmaceutical industry.
|
|
| Product Name | MF | CAS | Details |
|---|
| Ethyl 7-bromo-1-cyclopropyl-8- (difluoromethoxy)-4-oxo-1,4- dihydroquinoline-3-carboxylate | C16H14BrF2NO4 | 194805-07-7 | Details |
| Benzoic acid, 3-(cyclopropylmethoxy)-4-[(methylsulfonyl)amino]- | C12H15NO5S | 1702375-12-9 | Details |
| 1-Bromo-2-Methoxy-3- nitrobenzene | C7H6BrNO3 | 98775-19-0 | Details |
| Cyclobutanemethanol, 1-[[(5R)-2-chloro-6,7-dihydro-5-oxidothieno[3,2-d]pyrimidin-4-yl]amino]- | C11H14ClN3O2S | 1423719-36-1 | Details |
| hexahydro-1H-isoindole- 1,3(2H)-dione | C8H11NO2 | 1444-94-6 | Details |
| 3-(benzyloxy)-4-(difluoromethoxy)benzaldehyde | C15H12F2O3 | 577968-58-2 | Details |
| 2,4-dibromo-3-(difluoromethoxy)benzoic acid | C8H4Br2F2O3 | 223595-28-6 | Details |
| 2-((5-bromopyrimidin-2-yl)oxy)ethan-1-ol | C6H7BrN2O2 | 1246922-88-2 | Details |
| TERT-BUTYLMALONONITRILE | C7H10N2 | 4210-60-0 | Details |
| Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, ethyl ester | C17H25NO4 | 1027911-46-1 | Details |
| Tepotinib Hydrochloride Hydrate | C29H31ClN6O3 | 1946826-82-9 | Details |
| Decanoic acid, 10-[(2-hydroxybenzoyl)amino]-, sodium salt (1:1) | C17H26NNaO4 | 264602-55-3 | Details |
| Cis-4 - aMino- cyclohexanol hydrochloride | C6H14ClNO | 56239-26-0 | Details |
| Hyaluronic acid | C14H22NNaO11 | 9004-61-9 | Details |
| 1H-ISOINDOLE-1,3(2H)-DIONE, 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL]- | C21H21N3O5 | 446292-07-5 | Details |
| Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
| Aprocitentan | C16H14Br2N6O4S | 1103522-45-7 | Details |
| (S)-(-)-1-(2-Naphthyl)ethylamine | C12H13N | 3082-62-0 | Details |
| DIBENZYLPHOSPHORYL CHLORIDE | C14H14ClO3P | 538-37-4 | Details |
| Pregna-1,4,9(11)-triene-16α,17α-diol-3,20-dione 21-acetate | C23H28O6 | 77017-20-0 | Details |
| potassium decanoate | C10H21KO2 | 13040-18-1 | Details |
| ETHYL 10-BROMODECANOATE | C12H23BrO2 | 55099-31-5 | Details |
| Prucalopride | C18H26ClN3O3 | 179474-81-8 | Details |
| Lauroyl-L-carnitine | C19H37NO4 | 25518-54-1 | Details |
| Methyl 3-(cyclopropylMethoxy)-4-(difluoroMethoxy)benzoate | C13H14F2O4 | 680184-57-0 | Details |
| 2-(benzyloxy)-1-bromo-3- nitrobenzene | C13H10BrNO3 | 688363-79-3 | Details |
| 2-amino-6-bromophenol | C6H6BrNO | 28165-50-6 | Details |
| Octanoic acid, 8-bromo-, nonyl ester | C17H33BrO2 | 2089253-38-1 | Details |
| Butyrophenone | C10H12O | 495-40-9 | Details |
| Octanoic acid, 8-[(5-chloro-2-hydroxybenzoyl)amino]- | C15H20ClNO4 | 204852-67-5 | Details |
| Methyl 6-bromohexanoate | C7H13BrO2 | 14273-90-6 | Details |
| 3-(1-Piperazinyl)-1,2- benzisothiazole hydrochloride | C11H14ClN3S | 87691-88-1 | Details |
| 3-(1-Piperazinyl)-1,2- benzisothiazole | C11H13N3S | 87691-87-0 | Details |
| 1907685-94-2 | C17H18O3 | 1907685-94-2 | Details |
| (S)-(-)-1-(1-Naphthyl)ethylamine | C12H13N | 10420-89-0 | Details |
| Pyridinium chlorochromate | C5H5N.ClCrO3.H | 26299-14-9 | Details |
| 3-(3-Trifluoromethylphenyl)propionic acid | C10H9F3O2 | 585-50-2 | Details |
| 3-(Trifluoromethyl)benzenepropanol | C10H11F3O | 78573-45-2 | Details |
| rac 5-Hydroxymethyl Tolterodine | C22H31NO2 | 200801-70-3 | Details |
| METHYL 7-BROMOHEPTANOATE | C8H15BrO2 | 54049-24-0 | Details |
| [1-({(5R)-2-[4-(5-chloropyrimidin-2-yl)piperidin-1-yl]-5-oxido-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl}amino)cyclobutyl]methanol | C20H26ClN6O2S- | 1423719-30-5 | Details |
| 5-Norbornene-2,3- dicarboxyliciMide | C9H9NO2 | 3647-74-3 | Details |
| 2'-(benzyloxy)-3'-nitrobiphenyl-3-carboxylic acid | C20H15NO5 | 1636137-55-7 | Details |
| 1,4-DIMETHOXY-2-FLUOROBENZENE | C8H9FO2 | 82830-49-7 | Details |
| Cyclobutanemethanol, 1-[(2-chloro-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl)amino]- | C11H14ClN3OS | 1423719-34-9 | Details |
| 2-(3,4-dimethylphenyl)-5- methyl-1,2-dihydro-3Hpyrazol-3-one | C12H14N2O | 18048-64-1 | Details |
| Rivaroxaban iMpurity | C15H17N3O5 | 1616563-62-2 | Details |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate) | C24H33ClO8 | 960404-48-2 | Details |
| (S)-5-broMo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-aMine | C13H10BrCl2FN2O | 1448326-33-7 | Details |
| Hexanoic acid, 6-bromo-, 1,1-dimethylethyl ester | C10H19BrO2 | 65868-63-5 | Details |
| ACT-246475 | C28H39N6O8P | 1159500-34-1 | Details |
| Baloxavir marboxil | C27H23F2N3O7S | 1985606-14-1 | Details |
| 11-BROMOUNDECANOIC ACID ETHYL ESTER | C13H25BrO2 | 6271-23-4 | Details |
| 1416015-10-5 | C18H17Cl2F2NO3 | 1416015-10-5 | Details |
| 2-bromo-6-nitrophenol | C6H4BrNO3 | 13073-25-1 | Details |
| Diphosphoric acid, P,P,P',P'-tetrakis[(4-methylphenyl)methyl] ester | C32H36O7P2 | 1385889-18-8 | Details |
| Cinacalcet hydrochloride | C22H23ClF3N | 364782-34-3 | Details |
| Noreximide | C9H9NO2 | 6319-06-8 | Details |
| 2-(1-Hydroxy-3-methylbutylidene)-5,5-dimethyl-1,3-cyclohexanedione | C13H20O3 | 172611-72-2 | Details |
| 3'-amino-2'-hydroxybiphenyl-3-carboxylic acid | C13H11NO3 | 376592-93-7 | Details |
| Sodium decanoate | C10H19NaO2 | 1002-62-6 | Details |
| 3-bromo-2-methoxyaniline | C7H8BrNO | 116557-46-1 | Details |
| 4-BroMo-2-(phenylMethoxy)phenol | C13H11BrO2 | 153240-85-8 | Details |
| (R)-5-bromo-1-methyl-2- Tritylisoindoline | C28H24BrN | 194805-14-6 | Details |
| 2 H-1,3-BENZOXAZINE-2,4(3 H)-DIONE | C8H5NO3 | 2037-95-8 | Details |
| (4-Chlorophenoxy)acetyl chloride | C8H6Cl2O2 | 4122-68-3 | Details |
| (Bromomethyl)cyclopropane | C4H7Br | 7051-34-5 | Details |
| 8-[(2-hydroxybenzoyl)amino]octanoic acid | C15H21NO4 | 183990-46-7 | Details |
| 2'-hydroxy-3'-nitro-3- biphenylcarboxylic acid | C13H9NO5 | 376591-95-6 | Details |
| 4-N-BOC-AMINO-CYCLOHEXANOL | C11H21NO3 | 224309-64-2 | Details |
| 3-DifluoroMethoxy-4-hydroxybenzaldehyde | C8H6F2O3 | 53173-70-9 | Details |
| 2,3-Dihydrothieno[3,4-b][1,4]dioxine-2-carboxylic acid | C7H6O4S | 955373-67-8 | Details |
| Oxazole, 4-(chloromethyl)-2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]- | C14H14ClF2NO3 | 2103191-10-0 | Details |
| 2-Formylfuran-5-boronic acid | C5H5BO4 | 27329-70-0 | Details |
| Baxdrostat | C22H25N3O2 | 1428652-17-8 | Details |
| Potassium octanoate | C8H17KO2 | 764-71-6 | Details |
| 1-Piperazineacetamide, N-[trans-4-(acetylamino)cyclohexyl]-4-[5-(4-methylphenyl)-1,2,4-triazin-3-yl]- | C24H33N7O2 | 1820940-17-7 | Details |
| METHYL 4-ACETAMIDO-2-HYDROXYBENZOATE | C10H11NO4 | 4093-28-1 | Details |
| Ethyl 6-bromohexanoate | C8H15BrO2 | 25542-62-5 | Details |
| 1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- | C22H19N3O6 | 446292-08-6 | Details |
| SulfaMide, N-[5-(4-broMophenyl)-6-chloro-4-pyriMidinyl]-N'-propyl- | C13H14BrClN4O2S | 1393813-42-7 | Details |
| 2'-Methoxy-3'-nitrobiphenyl-3-carboxylic acid | C14H11NO5 | 376591-94-5 | Details |
| Potassium dibenzyl phosphate | C14H14KO4P | 78543-37-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||